Rajesh Rajalingam

Rajesh Rajalingam

Auto-generated profile, based on publicly available information

Rajesh Rajalingam

Department of HPB Surgery and Liver Transplantation, Institute of Liver Diseases and Transplantation, Dr. Rela Institute and Medical Centre, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu, India

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2021 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
AHAbdul Rahman Hakeem
Abdul Rahman Hakeem
RFRukhaiya Fathima
Rukhaiya Fathima
HPHrishikesh Padmanaban
Hrishikesh Padmanaban
KHKulaseharan Haribabu
Kulaseharan Haribabu
RRRajesh Rajalingam
Rajesh Rajalingam
MRMohamed Rela
Mohamed Rela

1 May 2022 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
DJDinesh Jothimani
Dinesh Jothimani
SDSilas Danielraj
Silas Danielraj
GNGomathy Narasimhan
Gomathy Narasimhan
IKIlankumaran Kaliamoorthy
Ilankumaran Kaliamoorthy
ARAkila Rajakumar
Akila Rajakumar
MRMohamed Rela
Mohamed Rela

5 March 2020 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
ARAshwin Rammohan
Ashwin Rammohan
MRMettu S. Reddy
Mettu S. Reddy
GNGomathy Narasimhan
Gomathy Narasimhan
RRRajesh Rajalingam
Rajesh Rajalingam
IKIlankumaran Kaliamoorthy
Ilankumaran Kaliamoorthy
MRMohamed Rela
Mohamed Rela

9 July 2024 in American Journal of Transplantation
Verified
Journal Article
Open access
RRRajesh Rajalingam
Rajesh Rajalingam
ARAshwin Rammohan
Ashwin Rammohan
SKShanmugam Arul Kumar
Shanmugam Arul Kumar
RCRamkiran Cherukuru
Ramkiran Cherukuru
UUUtpala Uday
Utpala Uday
MRMohamed Rela
Mohamed Rela

15 May 2015 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
GNGomathy Narasimhan
Gomathy Narasimhan
SGSanjay Govil
Sanjay Govil
RRRajesh Rajalingam
Rajesh Rajalingam
CVChandrasekaran Venkataraman
Chandrasekaran Venkataraman
NSNaresh P. Shanmugam
Naresh P. Shanmugam
MRMohamed Rela
Mohamed Rela
INTRODUCTION Primary Hyperoxaluria Type 1 (PH1) is ideally treated by liver-kidney transplantation once renal function has deteriorated beyond a certain point. Deceased donor synchronous combined liver-kidney transplantation is most commonly used to treat such patients. However in the living donor setting, the familial nature of this disease, need for two organs and the variable intensity of disease in the recipient challenge the principle of double equipoise that forms the basis of living donor transplantation. METHODS Patients' diagnosed with PH 1 and renal failure between October 2009 and February 2014 were treated with aggressive preoperative dialysis and liver-kidney transplantation. Dialysis was continued postoperatively for 72 hours. Patients were chosen for deceased donor combined liver-kidney transplantation, living donor synchronous liver kidney transplantation or living donor sequential liver-kidney transplantation according to donor availability and perceived systemic oxalate load. RESULTS Seven patients with PH 1 underwent liver kidney transplantation - either synchronously (2 from deceased donors, 3 from living donors) or sequentially (2 from living donors). Sibling donors underwent genetic testing to exclude disease prior to donation. Six of 7 patients had evidence of systemic oxalosis (Cardiomyopathy 6, Osteopathy 3, Retinopathy 1). One patient who underwent synchronous transplantation required retransplantation due to oxalate deposition in the transplanted kidney. Re-exploration for bleeding was necessary in 3 of 7 recipients. There were no donor complications. CONCLUSIONS Sequential LKT matches the greatest likelihood of successful outcome for the recipient with least risk to the donor, particularly in patients with clinical evidence of severe systemic oxalosis. Intensive perioperative hemodialysis is necessary to prepare these patients for surgery and protect the renal allograft from oxalate deposition when synchronous Liver-Kidney Transplantation is performed. This article is protected by copyright. All rights reserved.

1 January 2022 in Journal of Clinical and Experimental Hepatology
Verified
Journal Article
Closed access
NSNaresh Shanmugam
Naresh Shanmugam
JMJagadeesh Menon
Jagadeesh Menon
Mukul vijMukul vij
Mukul vij
ARAshwin Rammohan
Ashwin Rammohan
RRRajesh Rajalingam
Rajesh Rajalingam
MRMohamed Rela
Mohamed Rela